Newsroom
March 4, 2022
…the genetic and metabolic determinants of lupus phenotypes in CD4+ T cells, as well as the role of the microbiome in lupus pathogenesis. She is also conducting preclinical studies to…
March 4, 2022
…in CD4+ T cells, as well as the role of the microbiome in lupus pathogenesis. She is also conducting preclinical studies to explore the therapeutic potentials of treatments combining metabolic…
March 3, 2022
…Pacritinib (Vonjo) for myelofibrosis, approved in 2022. “Pacritinib is an important addition to the armamentarium we have for treating patients with myelofibrosis, in particular because of the safety and effectiveness…
March 1, 2022
…for treating patients with myelofibrosis, in particular because of the safety and effectiveness that has been seen for a subset of patients with myelofibrosis who have low platelet counts,” Dr….
February 24, 2022
The centerpiece of the first lady’s visit to the Mays Cancer Center was a listening session with experts about the cancer health disparities in the Latino community. Read story…
February 24, 2022
…she received here to treat lymphedema, which had caused severe swelling in her arm. Dr. Mesa said Mays Cancer Center is one of few places performing the procedure. The roundtable…
